Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2018-11-26 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LYON (69008), Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
GRANDE PHARMACIE DE MONPLAISIR : revenue, balance sheet and financial ratios
GRANDE PHARMACIE DE MONPLAISIR is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LYON (69008),
this company of category PME
shows in 2022 a revenue of 2.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - GRANDE PHARMACIE DE MONPLAISIR (SIREN 844676429)
Indicator
2023
2022
2021
2020
2019
Revenue
N/C
1 961 792 €
N/C
N/C
N/C
Net income
124 857 €
138 324 €
131 013 €
125 769 €
53 101 €
EBITDA
N/C
199 230 €
N/C
N/C
N/C
Net margin
N/C
7.1%
N/C
N/C
N/C
Revenue and income statement
In 2023, GRANDE PHARMACIE DE MONPLAISIR generates positive net income of 125 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2023: 53 k€ -> 125 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
124 857 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 180%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
179.513%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
30.897%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution GRANDE PHARMACIE DE MONPLAISIR
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
Debt ratio
1377.838
696.426
366.395
238.16
179.513
Financial autonomy
6.16
11.171
19.453
25.565
30.897
Repayment capacity
None
None
None
7.315
None
Cash flow / Revenue
None%
None%
None%
7.106%
None%
Sector positioning
Debt ratio
179.512023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average
In 2023, the debt ratio of GRANDE PHARMACIE DE MONPL... (179.51) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
30.9%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of GRANDE PHARMACIE DE MONPL... (30.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
7.32 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of GRANDE PHARMACIE DE MONPL... (7.32) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 166.85. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
166.85
Liquidity indicators evolution GRANDE PHARMACIE DE MONPLAISIR
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
Liquidity ratio
263.325
202.397
225.833
174.784
166.85
Interest coverage
None
None
None
10.234
None
Sector positioning
Liquidity ratio
166.852023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Average-23 pts over 3 years
In 2023, the liquidity ratio of GRANDE PHARMACIE DE MONPL... (166.85) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
10.23x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent
In 2022, the interest coverage of GRANDE PHARMACIE DE MONPL... (10.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution GRANDE PHARMACIE DE MONPLAISIR
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
Operating WCR
0 €
0 €
0 €
167 204 €
0 €
Inventory turnover (days)
0
0
0
30
0
Customer payment term (days)
0
0
0
4
0
Supplier payment term (days)
0
0
0
47
0
Positioning of GRANDE PHARMACIE DE MONPLAISIR in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of GRANDE PHARMACIE DE MONPLAISIR is estimated at
1 473 247 €
(range 895 952€ - 2 071 054€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
895k€1473k€2071k€
1 473 247 €Range: 895 952€ - 2 071 054€
NAF 5 année 2023
Valuation method used
Net Income Multiple
124 857 €
×
11.8x
=1 473 247 €
Range: 895 952€ - 2 071 055€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare GRANDE PHARMACIE DE MONPLAISIR with other companies in the same sector:
Frequently asked questions about GRANDE PHARMACIE DE MONPLAISIR
What is the revenue of GRANDE PHARMACIE DE MONPLAISIR ?
The revenue of GRANDE PHARMACIE DE MONPLAISIR in 2022 is 2.0 M€.
Is GRANDE PHARMACIE DE MONPLAISIR profitable?
Yes, GRANDE PHARMACIE DE MONPLAISIR generated a net profit of 125 k€ in 2023.
Where is the headquarters of GRANDE PHARMACIE DE MONPLAISIR ?
The headquarters of GRANDE PHARMACIE DE MONPLAISIR is located in LYON (69008), in the department Rhone.
Where to find the tax return of GRANDE PHARMACIE DE MONPLAISIR ?
The tax return of GRANDE PHARMACIE DE MONPLAISIR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does GRANDE PHARMACIE DE MONPLAISIR operate?
GRANDE PHARMACIE DE MONPLAISIR operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart